FDA Propels Insulin Affordability with Semglee

This content originally appeared on diaTribe. Republished with permission. By Karena Yan, Joseph Bell, and Arvind Sommi Semglee may provide a cheaper alternative to Lantus (insulin glargine) – it costs $148 for five pre-filled insulin pens. Semglee, which was approved last year as a new basal insulin for adults and children with type 1 diabetes […]

Semglee, A Low-Cost Basal Insulin, Comes to the US

This content originally appeared on diaTribe. Republished with permission. By Karena Yan and Joseph Bell A more affordable alternative to Lantus (insulin glargine) will cost $148 for five pre-filled insulin pens Mylan and Biocon Biologics announced last month the long-awaited US launch of Semglee, a new insulin aiming to be deemed “biosimilar” to insulin glargine (basal insulin) […]

Insulin Co-Payment Cap Bills

America has a unique problem: prescription drug prices are too expensive for many people. In 2018 alone, 1 in 5 Americans (or 37 million non-elderly adults) went without a prescription drug due to cost. One of the most egregious examples of the high cost of prescription drugs is the rising cost of insulin in the […]